The Washington Post examines the H1N1 vaccine plan CDC unveiled on Friday: "Vaccine for the H1N1 influenza pandemic will be distributed on a three-day turnaround time from four regional warehouses around the country next month. The vaccine deliveries, expected to equal 20 million doses a week by the end of October, will be distributed among 90,000 immunization 'providers,' including health departments, hospitals, clinics, doctors' offices and pharmacies." The newspaper continues, "Government planners expect demand for vaccine will outstrip supply in the first weeks after it becomes available. During that time, states will have to decide which hospitals, clinics and offices are most apt to reach the priority populations and thus should get vaccine first" (Brown, 9/19).

In related news, the pharmaceutical company Sanofi-Aventis on Monday announced it expects doses of its H1N1 vaccine to arrive in the U.S. by mid-October, the AP reports (9/21).

Slate examines the decision by U.S. health officials to order H1N1 vaccines that do not use adjuvants (Dobbs, 9/17).

Africa Reports 8,000 H1N1 Cases, 46 Deaths

Africa has confirmed 8,000 cases of the H1N1, which have led to 46 deaths, according to a WHO researcher, PANA/Afrique en ligne reports (9/17).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.